199 related articles for article (PubMed ID: 12369607)
1. Optimizing antidepressant treatment: efficacy and tolerability.
Deakin B; Dursun S
Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S13-24. PubMed ID: 12369607
[TBL] [Abstract][Full Text] [Related]
2. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression.
Kent JM
Lancet; 2000 Mar; 355(9207):911-8. PubMed ID: 10752718
[TBL] [Abstract][Full Text] [Related]
3. New developments in the treatment of depression.
Montgomery SA
J Clin Psychiatry; 1999; 60 Suppl 14():10-5; discussion 31-5. PubMed ID: 10408420
[TBL] [Abstract][Full Text] [Related]
4. Tolerability and safety: essentials in antidepressant pharmacotherapy.
Lader MH
J Clin Psychiatry; 1996; 57 Suppl 2():39-44. PubMed ID: 8626362
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion.
Horst WD; Preskorn SH
J Affect Disord; 1998 Dec; 51(3):237-54. PubMed ID: 10333980
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of milnacipran in comparison with other antidepressants.
Bisserbe JC
Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S43-50. PubMed ID: 12369610
[TBL] [Abstract][Full Text] [Related]
7. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression.
Fawcett J; Barkin RL
J Affect Disord; 1998 Dec; 51(3):267-85. PubMed ID: 10333982
[TBL] [Abstract][Full Text] [Related]
8. Development of new antidepressants.
Sambunaris A; Hesselink JK; Pinder R; Panagides J; Stahl SM
J Clin Psychiatry; 1997; 58 Suppl 6():40-53. PubMed ID: 9227672
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of antidepressants.
Frazer A
J Clin Psychopharmacol; 1997 Apr; 17 Suppl 1():2S-18S. PubMed ID: 9090573
[TBL] [Abstract][Full Text] [Related]
10. Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy.
Goodnick PJ
Ann Clin Psychiatry; 2001 Mar; 13(1):31-41. PubMed ID: 11465683
[TBL] [Abstract][Full Text] [Related]
11. New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.
Owen JR; Nemeroff CB
Depress Anxiety; 1998; 7 Suppl 1():24-32. PubMed ID: 9597349
[TBL] [Abstract][Full Text] [Related]
12. Are all antidepressants the same?
Möller HJ
J Clin Psychiatry; 2000; 61 Suppl 6():24-8. PubMed ID: 10775021
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of venlafaxine in comparison with other antidepressants.
Lecrubier Y
Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 2():29-35. PubMed ID: 7622815
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of action of antidepressants and therapeutic perspectives].
Bourin M; David DJ; Jolliet P; Gardier A
Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
[TBL] [Abstract][Full Text] [Related]
15. [Depression and pain: novel clinical, neurobiological and psychopharmacological data].
Jaracz J; Rybakowski J
Psychiatr Pol; 2005; 39(5):937-50. PubMed ID: 16358593
[TBL] [Abstract][Full Text] [Related]
16. Designing a new generation of antidepressant drugs.
Pinder RM
Acta Psychiatr Scand Suppl; 1997; 391():7-13. PubMed ID: 9265946
[TBL] [Abstract][Full Text] [Related]
17. Current trends in the development of new antidepressants.
Pacher P; Kohegyi E; Kecskemeti V; Furst S
Curr Med Chem; 2001 Feb; 8(2):89-100. PubMed ID: 11172668
[TBL] [Abstract][Full Text] [Related]
18. [1+1 or 2x1? Another form of dual antidepressive mechanism of action].
Lakatos L; Rihmer Z
Neuropsychopharmacol Hung; 2005 Sep; 7(3):118-24. PubMed ID: 16493875
[TBL] [Abstract][Full Text] [Related]
19. Third-generation antidepressants: do they offer advantages over the SSRIs?
Olver JS; Burrows GD; Norman TR
CNS Drugs; 2001; 15(12):941-54. PubMed ID: 11735614
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological principles of antidepressant efficacy.
Schatzberg AF
Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S17-22. PubMed ID: 12404665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
